Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Upgrade Now
NasdaqGM - Nasdaq Real Time Price USD

Apogee Therapeutics, Inc. (APGE)

Compare
35.61
-1.75
(-4.68%)
At close: April 1 at 4:00:00 PM EDT
35.61
0.00
(0.00%)
After hours: April 1 at 5:17:50 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
Operating Expense
216,870
216,870
93,003
30,727
Operating Income
-216,870
-216,870
-93,003
-30,727
Net Non Operating Interest Income Expense
34,742
34,742
9,018
-9,058
Pretax Income
-182,128
-182,128
-83,985
-39,785
Tax Provision
18
18
--
--
Net Income Common Stockholders
-182,146
-182,146
-83,985
-39,785
Diluted NI Available to Com Stockholders
-182,146
-182,146
-83,985
-39,785
Basic EPS
-3.30
--
-3.36
-1.46
Diluted EPS
-3.30
--
-3.36
-1.46
Basic Average Shares
55,193.97
--
25,005.77
27,246.82
Diluted Average Shares
55,193.97
--
25,005.77
27,246.82
Total Operating Income as Reported
-216,870
-216,870
-93,003
-30,727
Total Expenses
216,870
216,870
93,003
30,727
Net Income from Continuing & Discontinued Operation
-182,146
-182,146
-83,985
-39,785
Normalized Income
-182,146
-182,146
-83,985
-39,785
Interest Income
34,742
34,742
9,018
92
Interest Expense
--
--
--
9,150
Net Interest Income
34,742
34,742
9,018
-9,058
EBIT
-216,870
-216,870
-83,985
-30,635
EBITDA
-216,681
-216,681
-83,985
-30,635
Reconciled Depreciation
189
189
--
--
Net Income from Continuing Operation Net Minority Interest
-182,146
-182,146
-83,985
-39,785
Normalized EBITDA
-216,681
-216,681
-83,985
-30,635
12/31/2022 - 7/14/2023

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

SYRE Spyre Therapeutics, Inc.
15.30
-5.21%
 
ACLX Arcellx, Inc.
60.70
-7.47%
 
ORKA Oruka Therapeutics, Inc.
9.56
-6.82%
 
CRNX Crinetics Pharmaceuticals, Inc.
30.62
-8.71%
 
MRUS Merus N.V.
39.60
-5.92%
 
NUVL Nuvalent, Inc.
68.00
-4.12%
 
MLTX MoonLake Immunotherapeutics
36.35
-6.96%
 
EWTX Edgewise Therapeutics, Inc.
20.13
-8.50%
 
CNTA Centessa Pharmaceuticals plc
13.23
-8.00%
 
IMVT Immunovant, Inc.
15.20
-11.06%